| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |